Inhibition of invasion and metastasis of human liver cancer HCCLM3 cells by portulacerebroside A

Pharmaceutical Biology

Volumn 53, Issue 5, 2015, Pages 773-780

  Ji, Qian ^a   Zheng, Guo Yin ^b   Xia, Wei ^c   Chen, Jian Yu ^a   Meng, Xiong Yu ^a   Zhang, Hong ^a   Rahman, Khalid ^d   Xin, Hai Liang ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^d LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Aggression; Hepatoma; Migration; Natural product

Indexed keywords

CELL PROTEIN; CEREBROSIDE; GELATINASE A; GELATINASE B; MESSENGER RNA; METASTASIS ASSOCIATED PROTEIN 1; NUCLEOSIDE DIPHOSPHATE KINASE A; PORTULACEREBROSIDE A; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HCCLM3 CELL LINE; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CANCER CELL LINE; METASTASIS INHIBITION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; WESTERN BLOTTING; DOSE RESPONSE; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; PATHOLOGY; PORTULACA; PREVENTION AND CONTROL; TUMOR CELL LINE; TUMOR INVASION;

PORTULACA OLERACEA; PORTULACACEAE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; PLANT EXTRACTS; PORTULACA;

EID: 84924412019     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.941505     Document Type: Article

References (38)

1. Bago R, Pavelic J, Maravic Vlahovicek G, Bosnar MH. (2009). Nm23-H1 promotes adhesion of CAL 27 cells in vitro. Mol Carcinog 48: 779-89.
2. Cervoni L, Egistelli L, Eufemi M, et al. (2006). DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells. J Cell Biochem 98:421-8.
3. Chen YG, Shen ZJ, Chen XP. (2009). Evaluation of free radicals scavenging and immunity-modulatory activities of Purslane polysac-charides. Int J Biol Macromol 45:448-52.
4. Choudhuri T, Murakami M, Kaul R, et al. (2010). Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Cancer Biol Ther 9:1065-78.
5. Faried A, Faried LS, Usman N, et al. (2007). Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol 14:3593-601.
6. Gialeli C, Theocharis AD, Karamanos NK. (2011). Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278:16-27.
7. Hakem A, Sanchez-Sweatman O, You-Ten A, et al. (2005). RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 19:1974-9.
8. Hofer MD, Kuefer R, Varambally S, et al. (2004). The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64: 825-9.
9. Hofer MD, Tapia C, Browne TJ, et al. (2006). Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue. Arch Pathol Lab Med 130:989-96.
10. Iguchi K. (2012). Effect of bisphosphonates on anticancer activity in prostate cancer cells. Yakugaku Zasshi 132:1025-30.
11. Jiang L, Liu X, Kolokythas A, et al. (2010). Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127:505-12.
12. Johnson E, Seachrist DD, DeLeon-Rodriguez CM, et al. (2010). HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem 285:29491-501.
13. Jung S, Paek YW, Moon KS, et al. (2006). Expression of Nm23 in gliomas and its effect on migration and invasion in vitro. Anticancer Res 26:249-58.
14. Kar A, Saha D, Purohit G, et al. (2012). Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells. Nucleic Acids Res 40:2554-65.
15. Kumar A, El-Osta A, Hussain AA, Marshall J. (2010). Increased sequestration of matrix metalloproteinases in ageing human Bruch's membrane: Implications for ECM turnover. Invest Ophthalmol Vis Sci 51:2664-70.
16. Kumar R, Wang RA, Bagheri-Yarmand R. (2003). Emerging roles of MTA family members in human cancers. Semin Oncol 30:30-7.
17. Li Y, Chao Y, Fang Y, et al. (2013). MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. J Exp Clin Cancer Res 32:33. doi:10.1186/1756-9966-32-33.
18. Li YP, Zeng XW, Ye J, et al. (2009). Screening antitumor effect of active constituents from Portulaca oleracea L. in vitro and in vivo. Lishizhen Med Mater Med Res 20:2726-8.
19. Liu M, Bi F, Zhou X, Zheng Y. (2012). Rho GTPase regulation by miRNAs and covalent modifications. Trends Cell Biol 22:365-73.
20. Mardilovich K, Olson MF, Baugh M. (2012). Targeting Rho GTPase signaling for cancer therapy. Future Oncol 8:165-77.
21. McDermott WG, Boissan M, Lacombe ML, et al. (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin Exp Metastasis 25:131-8.
22. Novak M, Jarrett SG, McCorkle JR, et al. (2011). Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma. Naunyn Schmiedebergs Arch Pharmacol 384:433-8.
23. Paul A, Das S, Das J, et al. (2013). Diarylheptanoid-myricanone isolated from ethanolic extract of Myrica cerifera shows anticancer effectson HeLa and PC3 cell lines: Signalling pathway and drug-DNA interaction. J Integr Med 11:405-15.
24. Rathinam R, Berrier A, Alahari SK. (2011). Role of Rho GTPases and their regulators in cancer progression. Front Biosci 16:2561-71.
25. Rubaci AH, Kazancioglu HO, Olgac V, Ak G. (2012). The roles of matrix metalloproteinases-2,-7,-10 and tissue inhibitor of metallo-proteinase-1 in the pathogenesis of oral lichen planus. J Oral Pathol Med 41:689-96.
26. Struckhoff AP, Rana MK, Worthylake RA. (2011). RhoA can lead the way in tumor cell invasion and metastasis. Front Biosci 16:1915-26.
27. Thakur RK, Kumar P, Halder K, et al. (2009). Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res 37:172-83.
28. Tian JL, Liang X, Gao PY, et al. (2014). Two new alkaloids from Portulaca oleracea and their cytotoxic activities. J Asian Nat Prod Res 16:259-64.
29. Toh Y, Ohga T, Endo K, et al. (2004). Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110:362-7.
30. Ueno K, Hirata H, Majid S, et al. (2012). Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther 11: 244-53.
31. Valastyan S, Reinhardt F, Benaich N, et al. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-46.
32. Xin HL, Hou YH, Xu YF, et al. (2008). Portulacerebroside A: New cerebroside from Portulaca oleracea L. Chin J Nat Med 6:401-3.
33. Yan J, Sun LR, Zhou ZY, et al. (2012). Homoisoflavonoids from the medicinal plant Portulaca olerace. Phytochemistry 80:37-41.
34. Zhang H, Yang D, Wang H, et al. (2014). Metastasis-associated gene 1 promotes invasion and migration potential of laryngeal squamous cell carcinoma cells. Oncol Lett 7:399-404.
35. Zhang H, Yu CH, Jiang YP, et al. (2012a). Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice. PLoS One 7:e46574.
36. Zhang H, Zhang Y, Jiang YP, et al. (2012b). Curative effects of oleanolic acid on formed hypertrophic scars in the rabbit ear model. Evid-Based Compl Alt 2012:837581. doi: 10.1155/2012/837581.
37. Zheng GY, Qu LP, Yue XQ, et al. (2014). Portulacerebroside A induces apoptosis via activation of the mitochondrial death pathway in human liver cancer HCCLM3 cells. Phytochem Lett 7:77-84.
38. Zins K, Lucas T, Reichl P, et al. (2013). A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice. PLoS One 8:e74924.